罗氟司特哪些渠道可以购买

Roflumilast is a drug used to treat chronic obstructive pulmonary disease (COPD). It has been widely used worldwide to treat COPD and certain skin diseases. This article will introduce in detail the purchase channels, listing status and price of roflumilast. By knowing this information, patients can better plan how to get this medication.

Which channels can you buy Roflumilast?

Purchasing channels vary from region to region. The following are some common purchasing methods.

Hospital pharmacies

In many countries and regions, roflumilast can be purchased through hospital pharmacies. Patients need a doctor's prescription to purchase the drug at the hospital pharmacy. Hospital pharmacies can usually provide drugs from formal channels and ensure the quality of drugs.

Online pharmacies

Some online pharmacies also offer sales of roflumilast. Patients can purchase drugs through legitimate online pharmacies, but they need to pay attention to choosing a qualified platform to avoid buying fake and shoddy products. When purchasing online, patients should provide a valid prescription and ensure the pharmacy has good user reviews and certifications.

Medical service institutions

For areas where roflumilast is not yet available on the market, patients can consider obtaining the drug through medical service institutions. After placing an order, patients can obtain the drug through direct mail.

Understanding the purchase channels for roflumilast can help patients choose the most appropriate method of acquisition according to their own circumstances. Regardless of which option you choose, patients should ensure that their medications come from legitimate sources and avoid using uncertified medicines.

Roflumilast's marketing status

Roflumilast has been approved for marketing in many countries and regions around the world, but it is still not available in some regions. The following is the marketing status of roflumilast in different regions.

Not available in mainland China

Currently, roflumilast has not been approved for marketing in mainland China, which means that patients in mainland China cannot purchase this drug through formal channels. Patients may need to consider other treatment options or obtain the drug through international channels.

Listed in Hong Kong, China

Roflumilast has been approved for listing in Hong Kong, China. Patients in Hong Kong can purchase this drug at local hospital pharmacies or legal pharmacies with a doctor's prescription. The listing in Hong Kong provides patients in surrounding areas with more treatment options.

The launch of roflumilast in different regions reflects its global acceptance. For areas where it has not yet been launched, patients can follow relevant developments or obtain the drug through legal channels.

The price of roflumilast

The price of roflumilast varies by region and specification. The following is the reference price of roflumilast in different regions.

Price of the German version of AstraZeneca in the UK

Roflumilast produced by AstraZeneca in the UK, the export specification for the German version is 500μg*30 tablets, and the reference price is about US$233 per box. The specification is 500μg*90 tablets, and the reference price is about US$391 per box. These prices may vary by pharmacy and purchase channel.

The price of the Hong Kong version of AstraZeneca in the UK

The Hong Kong version of Roflumilast produced by AstraZeneca in the UK is exported to 500μg*30 tablets, and the reference price is about US$134 per box. Prices in Hong Kong are relatively low and may be more suitable for patients with limited budgets.

By understanding where roflumilast is available, available, and priced, patients can better plan how to obtain and use this drug. No matter which method is chosen, patients should ensure that the source of the drug is formal and used under the guidance of a doctor.